In Vitro Biological Testing Services

This contract involves providing in vitro biological testing services using advanced human cell-based models such as organ-on-a-chip systems and 3D tissue cultures. The primary goal is to evaluate medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats by assessing both efficacy and toxicology. Notably, the work excludes animal testing, emphasizing alternative, human-relevant testing methods. The contract is a subcontract opportunity under NAICS code 541620, issued by the Department of Defense, with proposals due by June 12, 2026. The project focuses on innovative, non-animal testing platforms to support the development of safer and more effective countermeasures for national defense. Specific location details for the place of performance and points of contact are not provided. This solicitation reflects a strategic push towards more ethical and potentially more predictive biological testing methodologies, underpinning research targets that address public safety and emergency preparedness against CBRN hazards.